返回 Agenda
[V5-S1] Call for Abstract Session
Session Chair(s)
Keiji Imai, MSc
Director, Medical Affairs, Hospital Business Unit, Pfizer Biopharmaceuticals Gro
Pfizer Japan Inc., Japan
Koichiro Yuji, MD, PhD, FACP
Project Associate Professor, The Institute of Medical Science
Japan
Three outstanding research speakers are selected for this year’s Call for Abstract session out of large number of applications from Japan and overseas through a rigorous selection process. Speakers show their knowledge, experience, and research suited to the theme of this annual meeting. Current hot topics will be beneficial to your future business in medicine development.
Speaker(s)
Why the New Data-Rich Collaborations May Risk Harming Us More than Helping Us
Kit Howard, MS
CDISC, United States
Senior Director, Standards Development & Education
Therapeutic Needs of Older Patients in the Era of Mobile Health
Dinah Duarte, MSc
European Medicines Agency, Netherlands
Signal Management Lead
Applications and Challenges of Machine Learning in Clinical Trials for Safety, Efficacy, and Operational Integrity Endpoints
Kelci Miclaus, PhD, MS
Veeva Systems, United States
Senior Director